Citation Impact
Citing Papers
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma
2005
Why do cancers have high aerobic glycolysis?
2004 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
PET in oncology: Will it replace the other modalities?
1997
High-Dose, Single-Fraction Image-Guided Intensity-Modulated Radiotherapy for Metastatic Spinal Lesions
2008
Molecular imaging in drug development
2008 Standout
18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients
2002
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
2014
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
1995
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)
2001
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
2002 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing
2008
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer
1993
Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers
2010
The detection rates and tumor clinical/pathological stages of whole-body FDG-PET cancer screening
2007
Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT
2017
Guidelines on the radical management of patients with lung cancer
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
2009
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Serum biomarkers in idiopathic pulmonary fibrosis
2010
Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
2011
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
2005
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Stereotactic body radiation therapy for oligometastases
2009
Cushing's syndrome
2015 Standout
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Head and neck cancer
2008 Standout
High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer
2013
Stereotactic body radiation therapy: a novel treatment modality
2009
Characteristics of Patients Who Developed Radiation Pneumonitis Requiring Steroid Therapy After Stereotactic Irradiation for Lung Tumors
2006
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non–small-cell lung cancer
2006
Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review
2013
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer
2008
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
The role of positron emission tomography (PET) in the management of lymphoma patients
1999
Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years
2006
Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients
2005
Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma
2005
CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer
2016
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease
2016
Lung cancer: current therapies and new targeted treatments
2016 Standout
Correlation of glucose consumption and tumor cell density in astrocytomas
1993
Using Biological Markers to Predict Risk of Radiation Injury
2007
Regulation of cancer cell metabolism
2011 Standout
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned
2014
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
2008
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
2014
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
2012
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
2002
Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer
2015
One‐Pot Functionalization of Graphene with Porphyrin through Cycloaddition Reactions
2011 StandoutNobel
Treatment of hepatocellular carcinoma
1997
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
2008
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
1999
Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner
2004
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Exploring the role of cancer stem cells in radioresistance
2008
Results of Orbital Preservation for Advanced Malignant Maxillary Sinus Tumors
2003
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Stereotactic Single-Dose Radiotherapy of Lung Metastases
2007
Using Positron Emission Tomography with [18F]FDG to Predict Tumor Behavior in Experimental Colorectal Cancer
2001
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
1998
18p-FDG PET is superior to67Ga SPECT in the staging of non-Hodgkin’s lymphoma
2004
Lymphedema beyond breast cancer
2010 Standout
Idiopathic pulmonary fibrosis
2011 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
2013
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
1998
A challenge to traditional radiation oncology
2004
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
1994 Standout
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience
2015
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Artificial intelligence in radiology
2018 Standout
Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer
2004
Cervical cancer
2019 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy
2008
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
2007
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Interstitial Lung Disease in Lung Cancer
2005
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
2004
Salvage surgery after high-dose radiotherapy
2017
Intra-tumoral distribution of 64Cu-ATSM: a comparison study with FDG
2003
Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.
1998
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Positron Emission Tomography Scanning: Current and Future Applications
2002
Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer
2013
In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
1995
Head and Neck Cancer
2020 Standout
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
2012
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Stereotactic Body Radiation Therapy in Multiple Organ Sites
2007
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma
2002
Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose
1998
Cancer treatment and survivorship statistics, 2016
2016 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Extracranial Stereotactic Radiation Delivery: Expansion of Technology Beyond the Brain
2003
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
Transoral laser microsurgery for treatment for hypopharyngeal cancer in 211 patients
2017
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Lysyl Oxidase: From Basic Science to Future Cancer Treatment
2012
Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography
1998
Works of Jun Itami being referenced
Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma
2007
Clinical outcomes of single‐fraction stereotactic radiation therapy of lung tumors
2006
Serum Levels of KL-6 for Predicting the Occurrence of Radiation Pneumonitis After Stereotactic Radiotherapy for Lung Tumors
2004
Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma
2004
Outcomes in Patients With Early-Stage Hypopharyngeal Cancer Treated With Radiotherapy
2009
FDG-PET for the evaluation of tumor viability after anticancer therapy
1994
FDG-PET for predicting the prognosis of malignant lymphoma
1994
Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies
2014
Squamous cell carcinoma of the maxillary sinus treated with radiation therapy and conservative surgery
1998
Non-Hodgkin's lymphoma confined to the nasal cavity: Its relationship to the polymorphic reticulosis and results of radiation therapy
1991
Stereotactic Body Radiotherapy for Lung Tumors at the Pulmonary Hilum
2010
Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
2010
Stereotactic single high dose irradiation of lung tumors under respiratory gating
2002
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
2007
Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.
1992
[Development of stereotactic irradiation system of body tumors under respiratory gating].
2002
Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
2000
[Clinical and pathological study of irradiation therapy in 24 patients with hepatocellular carcinoma].
1986
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
1991